Drug Type AAV based gene therapy |
Synonyms adeno-associated virus expresing CTLA4-IgG fusion protein (NIDCR) |
Target |
Mechanism CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors), Gene transference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sjogren's Syndrome | Discovery | US | - | |
Sjogren's Syndrome | Discovery | US | - |